Yale Bulletin and Calendar

May 16, 2008|Volume 36, Number 29|Four-Week Issue


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Early-stage bone cells may offer
possible estrogen replacement

Cells on their way to forming bone also produce an estrogen-like substance that mimics the naturally occurring female sex hormone estradiol, investigators at the Yale School of Medicine reported on May 12 in the online edition of the Proceedings of the National Academy of Sciences.

Researchers hope such a molecule might provide some of the benefits but, hopefully, not the health risk of traditional hormonal therapies for menopause and bone loss.

Researchers in the laboratories of Thomas L. McCarthy and Michael Centrella in the Department of Surgery isolated this estrogen-like molecule from rat-derived osteoblasts, or cells that can build bones.

As the osteoblasts differentiated in culture, they produced a molecule that the investigators tentatively termed “Ob-SERM.” This substance triggered several of the biochemical responses induced by estrogen receptor activation. The osteoblast-derived molecule, however, was in part functionally and chemically distinct from estradiol, raising hopes that it may be a safer alternative to traditional hormone replacement therapies.

Estradiol plays an important role in maintaining skeletal health by balancing the ongoing processes of bone resorption and bone formation that normally occur throughout life. Restoration of estrogen levels after menopause helps to mitigate some of the more harmful side effects of hormone loss that generally occur during aging. However, therapy with native estradiol has also been linked to increased risk of some kinds of cancers.

Other Yale medical school researchers who contributed to the study include Mary E. Clough and Caren M. Gundberg in the Department of Orthopaedics and Rehabilitation. The study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health.

— By Bill Hathaway


T H I SW E E K ' SS T O R I E S

Added sun does not lower breast cancer risk, warn experts

Yale affiliates are honored with election to prestigious societies

Strobel’s students rediscover sense of scientific ‘wonder’ . .

Yale to celebrate 307th graduation

Summertime at Yale

Scientist Joan Steitz wins nation’s largest prize in medicine

University names 18 future leaders as 2008 World Fellows

ENDOWED PROFESSORSHIPS

Architecture students helping to design Mideast Peace Park

China’s President Hu Jintao meets with participants in . . .

In Yale-led study, astronomers discover nine young galaxies . . .

Research on male mating behavior suggests brains may be unisex . . .

Paul Anastas honored as the founder of ‘green chemistry’

Town-gown partners honored with Elm-Ivy Awards

SCHOOL OF MEDICINE NEWS

Exhibits explore artist’s Liverpool years, British watercolors

Two student-curated shows focus on the medium of photography

Library creates digital archive of ‘oldest college daily’

Two seniors will study at the University of Cambridge as Gates Scholars

Campus leaders discuss strategies for increasing staff diversity

Former Bucknell chaplain is named new pastor of University Church

Professor Miroslav Volf will co-teach class with . . . Tony Blair

Council of Masters honors 10 juniors for their scholarship . . .

Conference focuses on ‘Women and Men in the Globalizing University’

The future of ‘Computers, Freedom and Privacy’ to be addressed . . .

Karyn Frick honored for contributions to women’s health

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home